
Conference Coverage
Latest Content

Novel CLL Therapies Prompt New Treatment Considerations

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

CCCA Associated With Longer Time to Diagnosis Vs Other Scarring Alopecias

Health Equity & Access Weekly Roundup: January 23, 2026

Shorts










Podcasts
Center on Health Equity & Access
All News

Phase 2 trial results show anlotinib with anthracyclines and ifosfamide yields a 30.8% ORR and an 82.7% DCR in advanced soft tissue sarcoma.

At the Orlando session of the Institute for Value-Based Medicine, clinicians delivering cancer care in Central Florida address restrictions from Medicare Advantage plans, which can affect access to innovative treatments for breast cancer, myeloma, and bladder cancer.

Health outcomes and inpatient costs improved for veterans when the federal government invested in preventing homelessness.

A randomized clinical trial found a voice-enabled virtual assistant reduced mental distress and improved quality of life, self-care, and glycemic control.

A multistakeholder study explores how law enforcement presence in EDs affects survivors of violence and outlines trauma-informed, patient-centered policy solutions.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Socioeconomic and demographic factors influenced amputation and recurrence rates in upper extremity soft tissue sarcoma.

Semaglutide shows promise in improving liver health and metabolic outcomes in MASH, enhancing steatohepatitis resolution and cardiometabolic measures.

A review of case studies found that patients with double seronegative myasthenia gravis (MG) had similarities in the ways their condition presented.

There is a shift happening in mental health care, with real-world data and holistic evaluations improving patient outcomes and reducing disparities.





















